Acorda Therapeutics Inc (ACORQ)
followers
·
Follow
Sector: | HEALTH CARE |
Industry: | PHARMACEUTICALS |
SIC: | BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) |
CEO: | Ronald Cohen |
Employees: | 130 |
Web site: | acorda.com |
TWO BLUE HILL PLAZA, PEARL RIVER, NY, 10965
914-347-4300
|
• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know
Date | Ratio |
---|---|
2021-01-04 | 1:6 |
2023-06-05 | 1:20 |
All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|
Acorda Therapeutics, Inc. develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS) Inbrija for the treatment of OFF periods in Parkinson's disease in Europe.
Please log in first to see chart